Target
Cytochrome P450 2C19
Ligand
BDBM50313678
Substrate
n/a
Meas. Tech.
ChEMBL_624626 (CHEMBL1111586)
IC50
>10000±n/a nM
Citation
 Lesuisse, DTiraboschi, GKrick, AAbecassis, PYDutruc-Rosset, GBabin, DHalley, FChâtreau, FLachaud, SChevalier, AQuarteronet, DBurgevin, MCAmara, CBertrand, PRooney, T Design of potent and selective GSK3beta inhibitors with acceptable safety profile and pharmacokinetics. Bioorg Med Chem Lett 20:2344-9 (2010) [PubMed]  Article 
Target
Name:
Cytochrome P450 2C19
Synonyms:
(R)-limonene 6-monooxygenase | (S)-limonene 6-monooxygenase | (S)-limonene 7-monooxygenase | CP2CJ_HUMAN | CYP2C19 | CYPIIC17 | CYPIIC19 | Cytochrome P450 2C19 (CYP2C19) | Cytochrome P450 2C19 [I331V] | Cytochrome P450-11A | Cytochrome P450-254C | Fenbendazole monooxygenase (4'-hydroxylating) | Mephenytoin 4-hydroxylase | P450-11A | P450-254C
Type:
Enzyme
Mol. Mass.:
55935.47
Organism:
Homo sapiens (Human)
Description:
P33261
Residue:
490
Sequence:
MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKIYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFMESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRGHMPYTDAVVHEVQRYIDLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFKKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVPPFYQLCFIPV
  
Inhibitor
Name:
BDBM50313678
Synonyms:
CHEMBL1093747 | N-(5-bromo-6-(4-hydroxyphenyl)-1H-indazol-3-yl)butyramide
Type:
Small organic molecule
Emp. Form.:
C17H16BrN3O2
Mol. Mass.:
374.232
SMILES:
CCCC(=O)Nc1n[nH]c2cc(c(Br)cc12)-c1ccc(O)cc1
Structure:
Search PDB for entries with ligand similarity: